|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li Y, Drabsch Y, Pujuguet P, Ren J, van
Laar T, Zhang L, van Dam H, Clément-Lacroix P and Ten Dijke P:
Genetic depletion and pharmacological targeting of αv integrin in
breast cancer cells impairs metastasis in zebrafish and mouse
xenograft models. Breast Cancer Res. 17:282015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu D, Zhou X, Yao L, Liu C, Jin F and Wu
Y: Clinical implications of the interleukin 27 serum level in
breast cancer. J Investig Med. 62:627–631. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Engelman JA: Targeting PI3K signalling in
cancer: opportunities, challenges and limitations. Nat Rev Cancer.
9:550–562. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu P, Cheng H, Roberts TM and Zhao JJ:
Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev
Drug Discov. 8:627–644. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kobayashi T, Deak M, Morrice N and Cohen
P: Characterization of the structure and regulation of two novel
isoforms of serum- and glucocorticoid-induced protein kinase.
Biochem J. 344:189–197. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vasudevan KM, Barbie DA, Davies MA,
Rabinovsky R, McNear CJ, Kim JJ, Hennessy BT, Tseng H, Pochanard P,
Kim SY, et al: AKT-independent signaling downstream of oncogenic
PIK3CA mutations in human cancer. Cancer Cell. 16:21–32. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Zhou D, Phung S, Masri S, Smith D
and Chen S: SGK3 is an estrogen-inducible kinase promoting
estrogen-mediated survival of breast cancer cells. Mol Endocrinol.
25:72–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi L, Wang K, Zhao M, Yuan X and Huang C:
Overexpression of PIP5KL1 suppresses the growth of human cervical
cancer cells in vitro and in vivo. Cell Biol Int. 34:309–315. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu J, Wan M, He Q, Bassett RL Jr, Fu X,
Chen AC, Shi F, Creighton CJ, Schiff R, Huo L and Liu D: SGK3 is
associated with estrogen receptor expression in breast cancer.
Breast Cancer Res Treat. 134:531–541. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu M, Chen L, Chan TH, Wang J, Li Y, Li
Y, Zeng TT, Yuan YF and Guan XY: Serum and glucocorticoid kinase 3
at 8q13.1 promotes cell proliferation and survival in
hepatocellular carcinoma. Hepatology. 55:1754–1765. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Zhou D and Chen S: SGK3 is an
androgen-inducible kinase promoting prostate cancer cell
proliferation through activation of p70 S6 kinase and up-regulation
of cyclin D1. Mol Endocrinol. 28:935–948. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gatti L, Cossa G, Tinelli S, Carenini N,
Arrighetti N, Pennati M, Cominetti D, De Cesare M, Zunino F,
Zaffaroni N and Perego P: Improved apoptotic cell death in
drug-resistant non-small-cell lung cancer cells by tumor necrosis
factor-related apoptosis-inducing ligand-based treatment. J
Pharmacol Exp Ther. 348:360–371. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang G, Miyake M, Lawton A, Goodison S
and Rosser CJ: Matrix metalloproteinase-10 promotes tumor
progression through regulation of angiogenic and apoptotic pathways
in cervical tumors. BMC Cancer. 14:3102014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Virós D, Camacho M, Zarraonandia I, García
J, Quer M, Vila L and León X: Prognostic role of MMP-9 expression
in head and neck carcinoma patients treated with radiotherapy or
chemoradiotherapy. Oral Oncol. 49:322–325. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thorsen SB, Christensen SL, Würtz SO,
Lundberg M, Nielsen BS, Vinther L, Knowles M, Gee N, Fredriksson S,
Møller S, et al: Plasma levels of the MMP-9: TIMP-1 complex as
prognostic biomarker in breast cancer: a retrospective study. BMC
Cancer. 13:5982013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang C, Ma HX, Jin MS, Zou YB, Teng YL,
Tian Z, Wang HY, Wang YP and Duan XM: Association of matrix
metalloproteinase (MMP)-2 and −9 expression with
extra-gastrointestinal stromal tumor metastasis. Asian Pac J Cancer
Prev. 15:4187–4192. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang B, Tang F, Zhang B, Zhao Y, Feng J
and Rao Z: Matrix metalloproteinase-9 overexpression is closely
related to poor prognosis in patients with colon cancer. World J
Surg Oncol. 12:242014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang YL, Chen CZ, Jin LP, Ji QQ, Chen YZ,
Li Q, Zhang XH and Qu JM: Effect and mechanism of the metastasis
suppressor gene BRMS1 on the migration of breast cancer cells. Int
J Clin Exp Med. 6:908–916. 2013.PubMed/NCBI
|
|
20
|
Wu Y, Jiang W, Wang Y, Wu J, Saiyin H,
Qiao X, Mei X, Guo B, Fang X, Zhang L, et al: Breast cancer
metastasis suppressor 1 regulates hepatocellular carcinoma cell
apoptosis via suppressing osteopontin expression. PLoS One.
7:e429762012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ventura BV, Quezada C, Maloney SC,
Fernandes BF, Antecka E, Martins C, Bakalian S, di Cesare S and
Burnier MN Jr: Expression of the metastasis suppressor BRMS1 in
uveal melanoma. Ecancermedicalscience. 8:4102014.PubMed/NCBI
|
|
22
|
Sheng XJ, Zhou YQ, Song QY, Zhou DM and
Liu QC: Loss of breast cancer metastasis suppressor 1 promotes
ovarian cancer cell metastasis by increasing chemokine receptor 4
expression. Oncol Rep. 27:1011–1018. 2012.PubMed/NCBI
|
